Cutaneous Adverse Reaction – Friday Pop Quiz – 11/16
505950595059
The patient developed this cutaneous adverse reaction 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication?
A). Epidermal growth factor receptor (EGFR) inhibitor
B.) Tumor necrosis factor (TNF)-alpha inhibitor
C.) Smoothened inhibitor
D.) BRAF inhibitor
E.) Programmed cell death (PD)-1 inhibitor
To find out the correct answer a …
The patient developed this cutaneous adverse reaction 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication?
A). Epidermal growth factor receptor (EGFR) inhibitor
B.) Tumor necrosis factor (TNF)-alpha inhibitor
C.) Smoothened inhibitor
D.) BRAF inhibitor
E.) Programmed cell death (PD)-1 inhibitor
To find out the correct answer a … Continue reading "Cutaneous Adverse Reaction – Friday Pop Quiz – 11/16"
The second of a two-part series with clinical pearls for your dermatology practice from the 2018 Coastal Dermatology Symposium. Be sure not to miss all the useful points in Part I.
From Dr. Julie Harper’s talk “The Latest on Acne”
OCPs are still a viable treatment for female patients with acne. You should be sure to take a thorough history to elucidate any risk factors for venous t … 
This October, I had that wonderful opportunity to attend the Coastal Dermatology Symposium and participate in the Derm Mentors Resident of Distinction competition. This informative and enlightening conference held against the gorgeous backdrop of Monterey, California, was packed with clinically oriented lectures focusing on everything from emerging therapies in psoriasis, to proper sunscreen usa … 
Physicians from throughout the Washington DC area recently convened at the Georgetown University MedStar Washington Hospital Center Hair Disorders Symposium, where distinguished experts in the field of hair disorders discussed the evaluation, work-up, and treatment of a wide variety of alopecias and scalp disorders. A treasure trove of clinical pearls was shared along the way, and the attendees le … 
A Recap of the JDD October Podcast
Seborrheic keratoses (SKs), though harmless, are one of the most common patient concerns. Their aesthetic impact makes them one of the most common dermatologic complaints, however treatment options are limited. In this special of the JDD podcast series, Dr. Adam Friedman discusses his group’s article “Managing Seborrheic Keratosis: Evolving Strategies an … 